DSG

Executive Summary

DSG is a US-based provider of a unified eClinical software platform for clinical trials, founded in 2008 and headquartered in San Diego. Its flagship platform, eCaseLink, integrates EDC/DDC, eCOA, eConsent, RTSM, and TeleVisit to support both traditional and decentralized trial models. The company offers a comprehensive, end-to-end solution designed to streamline data capture, study management, and participant engagement. As a private entity with no disclosed total funding or valuation, DSG operates in a competitive landscape alongside larger players like Medidata and Veeva. However, its focus on unified, decentralized trial capabilities positions it well for growth as the industry shifts toward hybrid and remote trials. The company's lack of public financials or recent news limits visibility into its market traction, but its established platform and decade-plus tenure suggest a solid operational foundation.

Upcoming Catalysts (preview)

• Q3 2026New Customer Partnership or Contract Win with a Top Pharma35% success
• Q4 2026Series A or B Funding Round Announcement40% success
• Q2 2026Major Platform Upgrade or AI-Enhanced Feature Release50% success